Brian C. Boursiquot

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia

John K. Lin, Benjamin Lerman, James I. Barnes et al. · Journal of Clinical Oncology · 2018 · 144 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase Inhibition

Brian C. Boursiquot, Emily C. Zabor, Ilya Glezerman et al. · Hypertension · 2017 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study

Adeyinka Adejumo, George Cholankeril, Umair Iqbal et al. · Digestive Diseases and Sciences · 2019 · 24 citations

Medicine, Health Services Administration, Clinical Epidemiology +16

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease

Adeyinka Adejumo, Donghee Kim, Umair Iqbal et al. · Journal of Palliative Medicine · 2019 · 23 citations · Full text

Medicine, Internal Medicine, End-of-life Care +13

Autonomic dysfunction post–acute COVID-19 infection

Amar D. Desai, Brian C. Boursiquot, Catherine J. Moore et al. · HeartRhythm Case Reports · 2021 · 23 citations · Full text

Medicine, Cardiology, Internal Medicine +12